Applied Health Economics and Health Policy

Title Publication Date Language Citations
Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review2023/10/29English
Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review2023/11/28English
Adding a Gene Expression Profile Test to Aid Differential Diagnosis and Treatment in Aggressive Large B-Cell Lymphoma: An Early Exploratory Economic Evaluation2023/11/28English
Conditional Funding Recommendations for Drugs in Canada: A Cross-Sectional Analysis2023/01/07English
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries2024/01/12English
An Optional Delinked Reward System: Making Pharmaceutical Innovation Work for Everyone2023/12/22English
Cost-Effectiveness Analysis of Systemic Therapy for Intensification of Treatment in Metastatic Hormone-Sensitive Prostate Cancer in India2024/01/10English
Do Informal Care Recipients Internalise Carer Burden? Examining the Impact of Informal Care Receipt on Health Behaviours2024/01/10English
Are Web-Based Valuation Surveys for Preference-Based Measures as Reliable as Face-to-Face Surveys? TTO, DCE and DCE with Duration2024/01/13English
Forecasting the Incremental Value to Society Created by a Class of New Prescription Drugs: A Proposed Methodology and Its Application to Treating Chronic Hepatitis C in India2022/03/11English
Acknowledgement to Referees2020/12/14English
Modeling Medicaid and Medicare Savings from Reduced Poverty and Disability to Promote Investment in Mental Health and Substance Use Interventions in the USA2020/03/18English
Incorporating Process Utility into Cost-Effectiveness Analysis via a Bolt-On Domain to the SF-6D: An Exploratory Study2021/03/30English
Acknowledgement to Referees2021/12/02English
Authors’ Reply to Garattini and Freemantle: “Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition”2020/02/03English
Comment on: “The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review”2018/10/29English
Authors’ Reply to Angelis and Kanavos: “Does MCDA Trump CEA?”2018/11/21English
Authors’ Reply to Luft: “Measuring the Volume-Outcome Relation for Complex Hospital Surgery”2017/06/03English
The Choice of Transcatheter Aortic Valve Implementation (TAVI): Do Patient Co-morbidity and Hospital Ownership Type Matter?2018/07/23English
Rich and Well Educated: Are These Requirements Necessary to Claim Healthcare Tax Credits in Italy?2017/12/07English
Acknowledgement to Referees2015/11/20English
Acknowledgement to Referees2014/11/13English
Erratum to: Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder2013/03/21English
Explaining the Health Costs Associated with Managing Intracranial Aneurysms in Italy2013/07/10English
A Review of “Cost Effectiveness Modelling for Health Technology Assessment: A Practical Course”2016/04/07English
An Economist’s Influence on Health Policy2014/08/27English
Measuring the Cost Effectiveness of HIV Prevention Interventions in the US: Pitfalls and Problems2015/02/28English
The Impact of Physicians’ Working Hours on Inappropriate Use of Outpatient Medicine in a Tertiary Hospital in China2019/12/27English
Acknowledgement to Referees2018/11/12English
Pharmaceutical Patents in Europe: Radical Reforms Rather Than Getting Rid?2021/11/29English